Guardant Health gains amid $292.5M verdict against Natera over false advertising claims

RossHelen/iStock via Getty Images Guardant Health ( NASDAQ: GH ) rose 9.5% at least partly after a North California jury awarded the company $292.5 million in a false advertising lawsuit against Natera ( NTRA ) over Guardant's Reveal oncology test.

Natera fell 1.8%. Guardant ( GH ) filed the lawsuit in May 2021.